Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Clinical trial NCT00148941 · COMPLETED

Trial details

NCT number: NCT00148941
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Acellular Pertussis Diphtheria

Start date: 2005-01-06
Primary completion: 2006-11-01
Enrollment: 4209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.